Tata Nifty MidSmall Hlthcr Idx RegIDCW-R
Empty
1–7 yearsInvestment Horizon
HNI,MATarget Segments
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation15.0%
Sharpe Ratio0.77
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Laurus Labs LtdServices11.84%
Lupin LtdServices7.57%
Aurobindo Pharma LtdServices7.09%
Fortis Healthcare LtdServices6.16%
Glenmark Pharmaceuticals LtdServices5.40%
Alkem Laboratories LtdServices4.78%
Mankind Pharma LtdServices4.36%
Ipca Laboratories LtdServices4.11%
Biocon LtdServices3.96%
Gland Pharma LtdServices3.55%
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)1.15%
Regulatory & Tax Information
INF277KA1BF5
ISINDailyDealing Frequency
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)